Logo image of BTMD

BIOTE CORP -A (BTMD) Stock Price, Quote, News and Overview

NASDAQ:BTMD - Nasdaq - US0906831039 - Common Stock - Currency: USD

4.26  +0.05 (+1.19%)

After market: 4.26 0 (0%)

BTMD Quote, Performance and Key Statistics

BIOTE CORP -A

NASDAQ:BTMD (3/7/2025, 8:08:49 PM)

After market: 4.26 0 (0%)

4.26

+0.05 (+1.19%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High8.44
52 Week Low4.03
Market Cap231.49M
Shares54.34M
Float23.67M
Yearly DividendN/A
Dividend YieldN/A
PE14.2
Fwd PE7.36
Earnings (Next)03-12 2025-03-12/amc
IPO03-02 2021-03-02


BTMD short term performance overview.The bars show the price performance of BTMD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30

BTMD long term performance overview.The bars show the price performance of BTMD in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30

The current stock price of BTMD is 4.26 USD. In the past month the price decreased by -11.43%. In the past year, price decreased by -24.47%.

BIOTE CORP -A / BTMD Daily stock chart

BTMD Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 66.89 824.51B
JNJ JOHNSON & JOHNSON 16.69 401.33B
NVO NOVO-NORDISK A/S-SPONS ADR 26.18 386.95B
AZN ASTRAZENECA PLC-SPONS ADR 21.41 240.28B
MRK MERCK & CO. INC. 12.39 239.09B
NVS NOVARTIS AG-SPONSORED ADR 14.56 228.26B
PFE PFIZER INC 8.59 151.49B
SNY SANOFI-ADR 14.24 148.55B
BMY BRISTOL-MYERS SQUIBB CO 53.59 123.97B
GSK GSK PLC-SPON ADR 8.29 81.62B
ZTS ZOETIS INC 28.78 76.29B
TAK TAKEDA PHARMACEUTIC-SP ADR 33.71 47.88B

About BTMD

Company Profile

BTMD logo image biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. The company is headquartered in Irving, Texas and currently employs 194 full-time employees. The company went IPO on 2021-03-02. The firm provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. The company also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.

Company Info

BIOTE CORP -A

1875 W. Walnut Hill Ln #100, Floor 5

Irving TEXAS US

Employees: 194

Company Website: https://haymakeracquisition.com/

Investor Relations: https://ir.biote.com/

Phone: 19724869346

BIOTE CORP -A / BTMD FAQ

What is the stock price of BIOTE CORP -A today?

The current stock price of BTMD is 4.26 USD. The price increased by 1.19% in the last trading session.


What is the ticker symbol for BIOTE CORP -A stock?

The exchange symbol of BIOTE CORP -A is BTMD and it is listed on the Nasdaq exchange.


On which exchange is BTMD stock listed?

BTMD stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for BIOTE CORP -A stock?

12 analysts have analysed BTMD and the average price target is 10.15 USD. This implies a price increase of 138.16% is expected in the next year compared to the current price of 4.26. Check the BIOTE CORP -A stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is BIOTE CORP -A worth?

BIOTE CORP -A (BTMD) has a market capitalization of 231.49M USD. This makes BTMD a Micro Cap stock.


How many employees does BIOTE CORP -A have?

BIOTE CORP -A (BTMD) currently has 194 employees.


What are the support and resistance levels for BIOTE CORP -A (BTMD) stock?

BIOTE CORP -A (BTMD) has a resistance level at 4.27. Check the full technical report for a detailed analysis of BTMD support and resistance levels.


Is BIOTE CORP -A (BTMD) expected to grow?

The Revenue of BIOTE CORP -A (BTMD) is expected to grow by 7.02% in the next year. Check the estimates tab for more information on the BTMD EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy BIOTE CORP -A (BTMD) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BIOTE CORP -A (BTMD) stock pay dividends?

BTMD does not pay a dividend.


When does BIOTE CORP -A (BTMD) report earnings?

BIOTE CORP -A (BTMD) will report earnings on 2025-03-12, after the market close.


What is the Price/Earnings (PE) ratio of BIOTE CORP -A (BTMD)?

The PE ratio for BIOTE CORP -A (BTMD) is 14.2. This is based on the reported non-GAAP earnings per share of 0.3 and the current share price of 4.26 USD. Check the full fundamental report for a full analysis of the valuation metrics for BTMD.


What is the Short Interest ratio of BIOTE CORP -A (BTMD) stock?

The outstanding short interest for BIOTE CORP -A (BTMD) is 2.88% of its float. Check the ownership tab for more information on the BTMD short interest.


BTMD Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

BTMD Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to BTMD. Both the profitability and the financial health of BTMD get a neutral evaluation. Nothing too spectacular is happening here.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BTMD Financial Highlights

Over the last trailing twelve months BTMD reported a non-GAAP Earnings per Share(EPS) of 0.3. The EPS increased by 236.36% compared to the year before.


Industry RankSector Rank
PM (TTM) 2.13%
ROA 5.05%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%37.5%
Sales Q2Q%12.79%
EPS 1Y (TTM)236.36%
Revenue 1Y (TTM)30.25%

BTMD Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to BTMD. The Buy consensus is the average rating of analysts ratings from 12 analysts.

For the next year, analysts expect an EPS growth of 174.18% and a revenue growth 7.02% for BTMD


Ownership
Inst Owners67.42%
Ins Owners27.6%
Short Float %2.88%
Short Ratio5.1
Analysts
Analysts83.33
Price Target10.15 (138.26%)
EPS Next Y174.18%
Revenue Next Year7.02%